Ido Margalit
Netanya (ISR)
Role(s):
C-Level Executive (CEO, CFO, etc.)
Infigo Diagnostics Ltd
Find More Startups
Startup
Location:
Netanya
Industry:
Healthcare
Year Founded:
2007
Number Employees:
1-10 people
Description:
Infigo's MIPdx platform technology based on plastic nano receptors serves as an alternative to antibody based detection and enables immediate, reliable and precise detection of analytes - peptides and small molecules in particular. MIPdx displaces many of the currently available quantitative tests from laboratories to Point of Care (POC) settings thereby enabling online and efficient treatment of patients.
We are currently seeking an additional investment of $2M in order to put our first product in the market by the end of 2011 and to develop further products specifically in the cardiovascular biomarker testing market.
The company is currently in need of a $300K convertible loan by the end of September 2010 to be used for:
A. Complete a major external "A" round fundraise
B. Finalize a deal with at least one of three notable strategic partners (further details will be handed after a signed NDA)
The company has been financed till now by angel investors.
The company has a detailed business plan and executive summary.
Please visit our website for further information about our technology, products and contact information.